Gynuity Health Projects: all 113 studies

Page 1 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Assessing the Efficacy and Acceptability of Two Missed Period Pills RegimensNot yet recruitingNCT06492889Phase 2/3
• Evaluation of Telemedicine Medical Abortion Service in EcuadorRecruitingNCT06270056
• Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control StudyCompletedNCT02610972Results posted
• Pain Control In First Trimester Medical Abortion: A Randomized TrialCompletedNCT01457521Phase 4Results posted
• Misoprostol for Treatment of Fetal Death at 14-28 Weeks of PregnancyCompletedNCT00671060Phase 3Results posted
• MA-ASAP at Independent Abortion Clinics: A Demonstration ProjectCompletedNCT05781061Not applicable
• Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan.CompletedNCT05459142
• Medication Abortion With Autonomous Self-Assessment ProjectCompletedNCT05278780Not applicable
• Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' GestationCompletedNCT05207644Phase 2
• Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 WeeksTerminatedNCT05119439Phase 4
• Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in NepalCompletedNCT05046041Phase 4
• Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.CompletedNCT05028387
• Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"Status unknownNCT04676776Phase 2
• Feasibility of Telemedicine Medical AbortionCompletedNCT04599725
• Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before AbortionTerminatedNCT04232189
• Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in ColombiaTerminatedNCT04063904Phase 4
• Assessing Medical Menstrual Regulation in the United StatesStatus unknownNCT03972358Phase 2
• Feasibility of Medical Abortion by Telemedicine in MexicoCompletedNCT03931460
• Urine and Serum Concentrations of Pregnancy-Associated Compounds During GestationCompletedNCT03552055
• Outpatient Service for Mid-trimester Termination of PregnancyCompletedNCT03346629Phase 4
• Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina FasoStatus unknownNCT03269279Phase 3
• Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion ServicesCompletedNCT03207880Not applicable
• The Association Between Shock Index and Severity of Postpartum Blood LossCompletedNCT03135158
• Simplifying First Trimester Medical Abortion Follow-upCompletedNCT03014193
• Acceptability and Feasibility of Medical Abortion in SingaporeCompletedNCT02985229Phase 3
• Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western UkraineCompletedNCT02981030Phase 4
• IV Versus IM Administration of Oxytocin for Postpartum BleedingCompletedNCT02954068Phase 4
• Introduction of UBT for PPH Management in Three CountriesCompletedNCT02910310Not applicable
• Misoprostol as First Aid Measure to Address Excessive Postpartum BleedingStatus unknownNCT02853552Phase 4
• Chart Review Study of Medical AbortionCompletedNCT02841072
• Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum HemorrhageCompletedNCT02805426Phase 4
• Measuring hCG Levels in Pregnant WomenCompletedNCT02763176
• A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 WeeksCompletedNCT02720991Phase 4
• A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester AbortionStatus unknownNCT02708446Phase 4
• Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations ResearchCompletedNCT02707653Not applicable
• Non-surgical Alternatives to Treatment of Failed Medical AbortionTerminatedNCT02704481Phase 4
• Semiquantitative Urine Pregnancy Test Results At ≥9 Weeks of GestationCompletedNCT02640378
• Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal DeathTerminatedNCT02633761Phase 3
• Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A SurveyCompletedNCT02611011
• Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy TestsCompletedNCT02570204Not applicable
• Simplified Medical Abortion Follow-UpTerminatedNCT02524990Not applicable
• Feasibility of Medical Abortion by Direct-to-Consumer TelemedicineCompletedNCT02513043
• Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in UkraineCompletedNCT02415894
• Acceptability and Feasibility of a Simplified Medical Abortion Regimen in GeorgiaCompletedNCT02398838Not applicable
• Simplified Medical Abortion Screening: A Pilot Demonstration ProjectCompletedNCT02381223
• Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and MexicoCompletedNCT02381210
• Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and MexicoStatus unknownNCT02381197
• Simplifying Menstrual Regulation (MR): Post Abortion Care in PakistanCompletedNCT02343913Not applicable
• Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled TrialTerminatedNCT02342002Phase 4
• Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of GestationCompletedNCT02314754Phase 4
• Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-UpCompletedNCT02299401Phase 2/3
• Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in UzbekistanCompletedNCT02235155
• Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in EgyptCompletedNCT02226588Phase 4
• Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the CaucasusCompletedNCT02219100Not applicable
• Treatment of Postpartum Hemorrhage With Misoprostol: Fever StudyCompletedNCT02163616Phase 3
• A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate RegimenCompletedNCT02091401Phase 4
• Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in KazakhstanCompletedNCT02018796
• Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days GestationCompletedNCT01966874
• Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation ServiceCompletedNCT01954069Not applicable
• 400mcg Sublingual Misoprostol as First Line TreatmentCompletedNCT01939457Not applicable
• Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility TreatmentCompletedNCT01919502Not applicable
• Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum HemorrhageCompletedNCT01914419Not applicable
• Oral Antihypertensive Regimens for Management of Hypertension in PregnancyCompletedNCT01912677Phase 4
• Study of Immediate Start of Progestin Contraceptives in Medical AbortionCompletedNCT01902485Phase 4
• Excellent BRASSS-V Drape™ Versus Indirect Measurement Protocol for Measurement of Postpartum Blood LossCompletedNCT01885845Not applicable
• Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days GestationCompletedNCT01856985Phase 4
• Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing PregnancyCompletedNCT01856777Not applicable
• Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility SettingCompletedNCT01846403Not applicable
• Exploring a Patient-centered Approach to Mifepristone Administration in Medical AbortionCompletedNCT01811056Not applicable
• Side Effects and Adherence Associated With Doxycycline Use Following Medical AbortionCompletedNCT01799252
• Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in BangladeshCompletedNCT01798017Phase 4
• Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)CompletedNCT01768299Phase 4
• Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in ArmeniaCompletedNCT01766388
• Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in SenegalCompletedNCT01713153Not applicable
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in CommunitiesWithdrawnNCT01710566Phase 3
• Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in EgyptCompletedNCT01619072Not applicable
• IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum HemorrhageCompletedNCT01608958Not applicable
• Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in NigeriaCompletedNCT01539408Phase 1
• A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)CompletedNCT01510574Not applicable
• Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsCompletedNCT01508429Not applicable
• Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in MaliWithdrawnNCT01487278Not applicable
• Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home BirthsCompletedNCT01485562Not applicable
• Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in IndiaCompletedNCT01462422Not applicable
• Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and UzbekistanCompletedNCT01410266Phase 4
• Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol AloneCompletedNCT01387256Phase 4
• R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical AbortionCompletedNCT01362387Not applicable
• Vaginal and Rectal Clostridial Carriage Among Women of Reproductive Age in the United StatesCompletedNCT01283828
• Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in TunisiaCompletedNCT01173003Not applicable
• The Acceptability and Feasibility of an Alternative to Routine Follow-up Visit After Medical Abortion in VietnamCompletedNCT01150422Phase 3
• Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-upCompletedNCT01150279
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum HemorrhageCompletedNCT01080846Not applicable
• Treatment Approaches to PreeclampsiaCompletedNCT01030627Phase 4
• The Extended Gestational Age Medical Abortion StudyCompletedNCT00997347Phase 4
• Uptake and Acceptability of Home-use of Mifepristone for Medical AbortionCompletedNCT00994734Not applicable
• Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))CompletedNCT00969982Not applicable
• Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)TerminatedNCT00957346Phase 3
• Topical Estriol for Vaginal HealthCompletedNCT00908570Phase 1
• Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)CompletedNCT00870272Not applicable
• Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded TrialCompletedNCT00784186Not applicable
• Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol AloneCompletedNCT00680394Not applicable

← Gynuity Health Projects overview and focus areas